The vast majority of people are getting both doses of the two-shot COVID-19 vaccines on time. Grand Rounds and Doctor on Demand announce plans to merge. And continuous glucose monitor companies are trying to reach the millions of diabetics, even though evidence about efficacy for some patients is still limited.
Hosted on Acast. See acast.com/privacy for more information.
